Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 7, Number 5—October 2001
Research

Rapid Emergence of Ciprofloxacin-Resistant Enterobacteriaceae Containing Multiple Gentamicin Resistance-Associated Integrons, the Netherlands

Alex van BelkumComments to Author , Wil Goessens, Cindy van der Schee, Nicole Lemmens-den Toom, Margreet C. Vos, Jan Cornelissen, Elly Lugtenburg, Siem de Marie, Henri Verbrugh, Bob Löwenberg, and Hubert Endtz
Author affiliations: Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands

Main Article

Table 2

Proportions of ciprofloxacin-resistant Enterobacter spp and Escherichia coli strains resistant to other antibioticsa

 Enterobacter
 E. coli
Antibiotic S (%) I (%) R (%) S (%) I (%) R (%)
Ceftazidime 24 (47) 0 27 (53) 46 (92) 0 4 (8)
Gentamicin 21(41) 6(12) 24(47) 28(56) 0 22(44)
Tobramycin 23 (45) 0 28 (55) 32 (64) 11 (22) 7 (14)
Amikacin 31 (61) 18 (35) 2 (4) 50 (100) 0 0
Cotrimoxazole 0 0 51 (100) 7 (14) 0 43 (86)
Imipenem 51 (100) 0 0 50 (100) 0 0
Colistin 12 (24) 0 39(76) 48(96) 0 0

aThe figures express the absolute number of susceptible (S), intermediate (I) and resistant (R) strains defined according to the 1999 NCCLS Guidelines [22].

Main Article

References
  1. Klastersky  J. Science and pragmatism in the treatment and prevention of neutropenic patients. J Antimicrob Chemother. 1998;41:13–24. DOIPubMedGoogle Scholar
  2. Emre  S, Sebastian  A, Chodoff  L, Boccagni  P, Meyers  B, Sheiner  PA, Selective decontamination of the digestive tract helps prevent bacterial infections in the early postoperative period after liver transplant. Mt Sinai J Med. 1999;66:310–3.PubMedGoogle Scholar
  3. Hsieh  WJ, Lin  HC, Hwang  SJ, Hou  MC, Lee  FY, Chang  FY, The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastro-intestinal bleeding. Am J Gastroenterol. 1998;93:962–6. DOIPubMedGoogle Scholar
  4. Carratalá  J, Fernández-Sevilla  A, Tubau  F, Dominguez  MA, Gudiol  F. Emergence of fluoroquinolone resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrob Agents Chemother. 1996;40:503–5.PubMedGoogle Scholar
  5. Oethinger  M, Conrad  S, Kaifel  K, Cometta  A, Bille  J, Klotz  G, Molecular epidemiology of fluoroquinolone resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers. Antimicrob Agents Chemother. 1996;40:387–92.PubMedGoogle Scholar
  6. Carratalá  J, Fernández-Sevilla  A, Tubau  F, Callis  M, Gudiol  F. Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin. Clin Infect Dis. 1995;20:557–60. DOIPubMedGoogle Scholar
  7. Cruciani  M, Rampazzo  R, Malena  M, Fazzarini  L, Todeschini  G, Messori  A, Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. Clin Infect Dis. 1996;23:795–805. DOIPubMedGoogle Scholar
  8. Lingnau  W, Berger  J, Javorsky  F, Fille  M, Allerberger  F, Benzer  H. Changing bacterial ecology during a five-year period of selective intestinal decontamination. J Hosp Infect. 1998;39:195–206. DOIPubMedGoogle Scholar
  9. Gairau  J, Xercavins  M, Rodriguez-Carballeira  M, Gomez-Vera  J-R, Coll  I, Vidal  D, Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother. 1999;43:2736–41.PubMedGoogle Scholar
  10. Blandino  G, Caccamo  F, di Marco  R, Speciale  A, Nicoletti  G. Epidemiology of antibiotic resistance in human isolates of enterobacteriaceae in Sicily. J Chemother. 1990;2:40–4.PubMedGoogle Scholar
  11. Diekema  DJ, Pfaller  MA, Jones  RN, Doern  GV, Winokur  PL, Gales  AC, Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada and Latin America for the SENTRY antimicrobial surveillance program, 1997. Clin Infect Dis. 1999;29:595–607. DOIPubMedGoogle Scholar
  12. Jamal  WY, El-Din  K, Rotimi  VO, Chugh  TD. An analysis of hospital-acquired bacteraemia in intensive care unit patients in a university hospital in Kuwait. J Hosp Infect. 1999;43:49–56. DOIPubMedGoogle Scholar
  13. Bornet  C, Davin-Regli  A, Bosi  C, Pages  JM, Bollet  C. Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability. J Clin Microbiol. 2000;38:1048–52.PubMedGoogle Scholar
  14. Bosi  C, Davin-Regli  A, Bornet  C, Mallea  M, Pages  JM, Bollet  C. Most Enterobacter aerogenes strains in France belong to a prevalent clone. J Clin Microbiol. 1999;37:2165–9.PubMedGoogle Scholar
  15. Ronveaux  O, de Gheldre  Y, Glupczynski  Y, Struelens  M, de Mol  P. Emergence of Enterobacter aerogenes as a major antibiotic-resistant nosocomial pathogen in Belgian hospitals. Clin Microbiol Infect. 1999;5:622–7. DOIPubMedGoogle Scholar
  16. Digranes  A, Solberg  CO, Sjursen  H, Skovlund  E, Sander  J. Antibiotic susceptibility of blood culture isolates of enterobacteriaceae from six Norwegian hospitals, 1991-1992. APMIS. 1997;105:854–60. DOIPubMedGoogle Scholar
  17. Osterblad  M, Pensala  O, Peterzens  M, Heleniusc  H, Huovinen  P. Antimicrobial susceptibility of enterobacteriaceae isolated from vegetables. J Antimicrob Chemother. 1999;43:503–9. DOIPubMedGoogle Scholar
  18. Bennett  PM. Integrons and gene cassettes: a genetic construction kit for bacteria. J Antimicrob Chemother. 1999;43:1–4. DOIPubMedGoogle Scholar
  19. Fluit  AC, Schmitz  FJ. Class I integrons, gene cassettes, mobility and epidemiology. Eur J Clin Microbiol Infect Dis. 1999;18:761–70. DOIPubMedGoogle Scholar
  20. Mazel  D, Davies  J. Antibiotic resistance in microbes. Cell Mol Life Sci. 1999;56:742–54. DOIPubMedGoogle Scholar
  21. Chiew  YF, Yeo  SF, Hall  LM, Livermore  DM. Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomycin versus enterobacteriaceae. J Antimicrob Chemother. 1998;41:247–51. DOIPubMedGoogle Scholar
  22. National Committee for Clinical Laboratory Standards. Performance guidelines for antimicrobial susceptibility testing: Fifth Informational Supplement M100-5. Villanova (PA): American Society for Microbiology; 1994.
  23. Boom  R, Sol  CJA, Salimans  MMM, Jansen  CL, Wertheim van Dillen  PME, van der Noorda  J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990;28:495–503.PubMedGoogle Scholar
  24. Levesque  C, Piche  L, Larose  C, Roy  PH. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother. 1995;39:185–91.PubMedGoogle Scholar
  25. Van Belkum  A, van Leeuwen  W, Kluytmans  J, Verbrugh  HA. Molecular nosocomial epidemiology: high speed typing of microbial pathogens by arbitrary primed polymerase chain reaction assays. Infect Control Hosp Epidemiol. 1995;16:658–66. DOIPubMedGoogle Scholar
  26. Versalovic  J, Koeuth  T, Lupski  JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 1991;19:6823–31. DOIPubMedGoogle Scholar
  27. Shi  ZY, Liu  PYF, Lau  YJ, Lin  YH, Hu  BS. Epidemiological typing of isolates from an outbreak of infections with multi-drug resistant Enterobacter cloacae by repetitive extragenic palindromic unit b1-primed PCR and pulsed field gel electrophoresis. J Clin Microbiol. 1996;34:2784–90.PubMedGoogle Scholar
  28. Tenover  FC, Arbeit  RD, Goehring  RV, Mickelsen  PA, Murray  BE, Persing  DH, Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–9.PubMedGoogle Scholar
  29. De Gheldre  Y, Maes  N, Rost  F, de Ryck  R, Clevenbergh  P, Vincent  JL, Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance. J Clin Microbiol. 1997;35:152–60.PubMedGoogle Scholar
  30. Haertl  R, Bandlow  G. Epidemiological fingerprinting of Enterobacter cloacae by small-fragment restriction endonuclease analysis and pulsed field gel electrophoresis of genomic restriction fragments. J Clin Microbiol. 1993;31:128–33.PubMedGoogle Scholar
  31. Van Nierop  WH, Duse  AG, Stewart  RG, Bilgeri  YR, Koornhof  HJ. Molecular epidemiology of an outbreak of Enterobacter cloacae in the neonatal intensive care unit of a provincial hospital in Gauteng, South Africa. J Clin Microbiol. 1998;36:3085–7.PubMedGoogle Scholar
  32. Van Kraaij  MGJ, Dekker  AW, Peters  E, Fluit  A, Verdonk  LF, Rozenberg-Arska  M. Emergence and infectious complications of ciprofloxacin resistant Escherichia coli in haematological cancer patients. Eur J Clin Microbiol Infect Dis. 1998;17:591–9. DOIPubMedGoogle Scholar
  33. Collis  CM, Hall  RM. Expression of antibiotic resistance genes in the integrated cassettes of integrons. Antimicrob Agents Chemother. 1995;39:155–62.PubMedGoogle Scholar
  34. Brown  HJ, Stokes  HW, Hall  RM. The integrons In0, In2 and In5 are defective transposon derivatives. J Bacteriol. 1996;178:4429–37.PubMedGoogle Scholar
  35. Kholodii  GY, Mindlin  SZ, Bass  IA, Yurieva  OV, Minakhina  SV, Nikiforov  VG. Four genes, two ends and a res region are involved in transposition of Tn5053: a paradigm for a novel family of transposons carrying either a mer operon or an integron. Mol Microbiol. 1995;17:1189–200. DOIPubMedGoogle Scholar
  36. Martinez-Freijo  P, Fluit  AC, Schmitz  FJ, Greks  VS, Verhoef  J, Jones  ME. Class I integrons in gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. J Antimicrob Chemother. 1998;42:689–96. DOIPubMedGoogle Scholar
  37. Martinez-Freijo  P, Fluit  AC, Schmitz  FJ, Verhoef  J, Jones  ME. Many class I integrons comprise distinct stable structures occurring in different species of enterobacteriaceae isolated from widespread geographic regions in Europe. Antimicrob Agents Chemother. 1999;43:686–9.PubMedGoogle Scholar
  38. Sundstrom  L. The potential of integrons and connected programmed rearrangements for mediating horizontal gene transfer. APMIS. 1998;84:37–42. DOIPubMedGoogle Scholar
  39. Sallen  B, Rajoharison  A, Desvarenne  S, Mabilat  C. Molecular epidemiology of integron-associated antibiotic resistance genes in clinical isolates of enterobacteriaceae. Microb Drug Resist. 1995;1:195–202. DOIPubMedGoogle Scholar

Main Article

Page created: April 26, 2012
Page updated: April 26, 2012
Page reviewed: April 26, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external